IQVIA HOLDINGS Resumen de negocios
- desarrollo de soluciones y servicios de investigación por contrato y desarrollo clínico (54,5%): ayuda a las empresas biofarmacéuticas, a los investigadores médicos y a los profesionales de la salud a optimizar sus estudios clínicos, a desarrollar nuevas clases terapéuticas, a identificar las necesidades de tratamiento y a evaluar la eficacia de los productos farmacéuticos con vistas a mejorar los resultados clínicos y científicos;
- desarrollo de soluciones tecnológicas y analíticas (39.9%): servicios relacionados con la información, el análisis, la consultoría estratégica, los estudios de marketing y de mercado sanitario a corto plazo, la externalización de procesos empresariales y la gestión de bases de datos médico-administrativas, todos ellos destinados a optimizar el rendimiento y las estrategias comerciales de las empresas farmacéuticas y del personal sanitario;
- servicios integrados (5,6%): desarrollo e implementación de soluciones personalizadas y programas de compromiso con el cliente, servicios sanitarios, servicios científicos y médicos, etc.
Las ventas netas se distribuyen geográficamente de la siguiente manera: América (49,4%), Europa y África (31,4%) y Asia/Pacífico (19,2%).
Ventas por actividad
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Research and Development Solutions
56,0
%
| 7 921 | 55,0 % | 8 395 | 56,0 % | +5,98 % |
Technology and Analytics Solutions
39,1
%
| 5 746 | 39,9 % | 5 862 | 39,1 % | +2,02 % |
Contract Sales and Medical Solutions
4,9
%
| 743 | 5,2 % | 727 | 4,9 % | -2,15 % |
Ventas por región
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
45,0
%
| 6 052 | 42,0 % | 6 743 | 45,0 % | +11,41 % |
Europe and Africa
29,8
%
| 4 366 | 30,3 % | 4 459 | 29,8 % | +2,13 % |
Asia-Pacific
19,8
%
| 2 996 | 20,8 % | 2 973 | 19,8 % | -0,77 % |
Americas
5,4
%
| 996 | 6,9 % | 809 | 5,4 % | -18,74 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03/10/16 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 01/08/20 |
James Berkshire
COO | Chief Operating Officer | 51 | 01/07/17 |
Jeffrey Spaeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karl Guenault
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/17 |
W. Staub
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/11/16 |
Nick Childs
IRC | Investor Relations Contact | - | 01/04/21 |
| Comptroller/Controller/Auditor | 40 | 01/03/19 | |
Joanne Hackett
PRN | Corporate Officer/Principal | 45 | - |
Michael Stibilj
PRN | Corporate Officer/Principal | 55 | 01/07/17 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 03/10/16 |
Colleen Goggins
BRD | Director/Board Member | 68 | 27/07/17 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03/10/16 |
John Connaughton
BRD | Director/Board Member | 58 | 01/01/08 |
Jim Fasano
BRD | Director/Board Member | 54 | 03/10/16 |
John Leonard
BRD | Director/Board Member | 66 | 05/02/15 |
Todd Sisitsky
BRD | Director/Board Member | 52 | 01/01/16 |
Carol Burt
BRD | Director/Board Member | 66 | 21/02/19 |
Sheila Stamps
BRD | Director/Board Member | 66 | 26/01/22 |
Leslie Morris
BRD | Director/Board Member | 53 | 24/01/22 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 257 900 000 | 180 519 606 ( 70,00 %) | 75 700 000 ( 29,35 %) | 70,00 % |
Información de la empresa
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
Aecio IT Solutions India Pvt Ltd.
| |
Data Processing Services
| |
IMS Health BV
| |
IQVIA Ltd.
 IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. |
Information Technology Services
|
Q Squared Solutions (India) Pvt Ltd.
 Q Squared Solutions (India) Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2015, Q Squared Solutions (India) Pvt Ltd. is a business services company. Part of IQVIA Holdings, Inc., the company is based in Mumbai, India. |
Miscellaneous Commercial Services
|
Excel Life Sciences Pvt Ltd.
| |
Quintiles Phase One Clinical Trials India Pvt Ltd.
| |
MediNeos Srl
 MediNeos Srl Miscellaneous Commercial ServicesCommercial Services MediNeos Srl operates as a contract research organization specialized in the design and conduct of observational studies. The firm provides strategic consultancy, feasibility studies, site management and clinical monitoring, data management, and international project management services. The company was founded by Giovanni Fiori in 2003 and is headquartered in Modena, Italy. |
Miscellaneous Commercial Services
|
IQVIA RDS Italy Srl
 IQVIA RDS Italy Srl Miscellaneous Commercial ServicesCommercial Services Part of IQVIA Holdings, Inc., IQVIA RDS Italy Srl is a company based in Milan, Italy that offers comprehensive and flexible solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients faster. The Italian company provides innovative pharmacovigilance solutions powered by the IQVIA core, which includes integrated, scalable technologies combined with data, advanced analytics, and deep domain expertise. The company's solutions include dynamic monitoring of structured and unstructured data, single platform source data verification, enablement of decentralized trials, intuitive and automated functionality to improve data quality, audit-ready clinical trials, stronger partnerships between subjects, sites, and sponsors, and interoperable solutions that connect with internal systems and their suite of products. Additionally, IQVIA RDS Italy offers expertise across the generics lifecycle to navigate the complex patent landscape and maximize opportunity. |
Miscellaneous Commercial Services
|
Sector
Ventas por actividad
Ventas por región
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +44,48 % | 54,04 mil M | |
| +43,57 % | 41,96 mil M | |
| -7,59 % | 28,35 mil M | |
| +12,30 % | 26,35 mil M | |
| -21,83 % | 19 mil M | |
| +7,15 % | 13 mil M | |
| +29,40 % | 12,28 mil M | |
| +25,15 % | 12,19 mil M | |
| -6,31 % | 11,49 mil M |
